PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
The Asset Exchange Ltd is an asset-backed lender within the UK used car finance market providing cars and loans to borrowers who are unable to use traditional lending sources for vehicle finance. They use compliant Hire Purchase Agreements which provides customers with high levels of consumer protection.
days to go:
Expired
investment:
£63,064
Polysolar specialises in manufacturing photovoltaic windows capable of generating electricity, which can be used in buildings to generate clean renewable energy whilst also meeting planning regulations. Its technology is already in-use by major organisations such as Network Rail and Sainsbury's.
days to go:
Expired
investment:
£1,311,180
Folio is an automated savings App, allowing users to create intelligent savings goals easily. They have over 4000 active users and are growing by 6% every week. Folio aim to help people build better financial habits by focusing on the future.
days to go:
Expired
investment:
£183,360
AQai is an Adaptability Quotient (AQ) assessment and coaching platform. It assesses workforce adaptability across 15 dimensions including resilience, grit and unlearning, motivation style, hope, and stress. It then deploys Artificial Intelligence (AI) and Machine Learning (ML) to deliver optimum learning strategies to its users so that they can adapt to changing work conditions. The term 'AQ' has featured in publications like Inc, Forbes, HBR, and the BBC to name a few. The company aims to be one of the leading companies in the $21 billion workforce adaptability sector. AQai's users are from over 52 countries and organisations like GSK, Philips, and FedEx. It has partnerships with companies based in India, Europe, the UAE, and the USA, and has sold 2,500 assessments till date. The company will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£138,540
FairMoney is a Price Comparison Website (PCW) specialising in comparing loans for consumers using machine intelligence. They ensure consumers receive the most appropriate loan by taking into account the lender's underwriting criteria, as well as the borrower's credit situation by using their proprietary algorithms.
days to go:
Expired
investment:
£200,000
